Legal Representation
Attorney
Valerie Brennan
USPTO Deadlines
Next Deadline
7 days remaining
Published for Opposition
Due Date
January 01, 2026
Extension Available
Until February 01, 2026
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 2, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 2, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 4, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 3, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 9, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 30, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 30, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 23, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 23, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development in the pharmaceutical field; conducting clinical trials for others in the field of cardiovascular medicine
First Use Anywhere:
Aug 1, 2017
First Use in Commerce:
Aug 1, 2018
Additional Information
Design Mark
The mark consists of the words "CARDURION" and "PHARMA" stacked to the right of a stylized heart-shaped design made up of the lower case letters c, d, and p, with the c and p shown mirrored.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
CDP CARDURION PHARMACEUTICALS
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"